Cited by 14Bone health and osteoporosis researchThyroid Disorders and TreatmentsHIV-related health complications and treatments

Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: A nested study within a randomized placebo controlled trial

Open access
Büchi, Annina Elisabeth, Feller, Martin, Netzer, Seraina, Blum, Manuel R., Gonzalez Rodriguez, Elena, Collet, Tinh-Hai, Del Giovane, Cinzia, van Heemst, Diana +9 more·2022·Bone

Abstract

The effect of levothyroxine (LT4) therapy for subclinical hypothyroidism (SHypo) on appendicular bone geometry and volumetric density has so far not been studied. In a nested study within the randomized, placebo-controlled Thyroid Hormone Replacement for Subclinical Hypothyroidism (TRUST) trial, we assessed the effect of LT4 therapy on bone geometry as measured by peripheral quantitative computed tomography (pQCT). In the TRUST trial, community-dwelling adults aged ≥65 years with SHypo were randomized to LT4 with dose titration vs. placebo with mock titration. We analyzed data from participants enrolled at the TRUST site in Bern, Switzerland who had bone pQCT measured at baseline and at 1 to 2 years follow-up. The primary outcomes were the annual percentage changes of radius and tibia epi- and diaphysis bone geometry (total and cortical cross-sectional area (CSA) and cortical thickness), and of volumetric bone mineral density (bone mineral content (BMC) and total, trabecular and cortical volumetric bone mineral density (vBMD)). We performed linear regression of the annual percentage changes adjusted for sex, LT4 dose at randomization and muscle cross-sectional area. The 98 included participants had a mean age of 73.9 (±SD 5.4) years, 45.9% were women, and 12% had osteoporosis. They were randomized to placebo (n = 48) or LT4 (n = 50). Annual changes in BMC and vBMD were similar between placebo and LT4-treated groups, without significant difference in bone geometry or volumetric bone mineral density changes, neither at the diaphysis, nor at the epiphysis. For example, in the placebo group, epiphyseal BMC (radius) decreased by a mean 0.2% per year, with a similar decrease of 0.5% per year in the LT4 group (between-group difference in %ΔBMC 0.3, 95% CI -0.70 to 1.21, p = 0.91). Compared to placebo, LT4 therapy for an average 14 months had no significant effect on bone mass, bone geometry and volumetric density in older adults with subclinical hypothyroidism. TRIAL REGISTRATION: The trial was registered on ClinicalTrials.gov numbers NCT01660126 (TRUST Thyroid trial) and NCT02491008 (Skeletal outcomes).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bone.2022.116404

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LT4 therapy did not affect bone microarchitecture.

    “Büchi et al. [34] indicated that LT4 therapy did not affect bone microarchitecture, which supports our findings.”

    From Effects of levothyroxine therapy on bone and mineral metabolism in hypothyroidism: a systematic review and meta-analysis (2025) · cites this paper as [34]

    The Discussion reports no detected effect of LT4 on bone geometry or volumetric bone mineral density in adults aged 65 or older with subclinical hypothyroidism. The study did not report a direct measure of bone microarchitecture, so the citation supports a narrower claim than the one made. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. R. Yang, L. Yao, Y. Fang, et al., The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies, J. Bone Miner. Metab. 36 (2) (Mar 2018) 209-220.
  2. E. Moser, T. Sikjaer, L. Mosekilde, L. Rejnmark, Bone indices in thyroidectomized patients on long-term substitution therapy with levothyroxine assessed by DXA and HR-pQCT, J. Thyroid. Res. 2015 (2015), 796871.
  3. Z. Javed, T. Sathyapalan, Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits, Ther.Adv.Endocrinol. Metab. 7 (1) (Feb 2016) 12-23.

Cited by

Sorted by citations

Authors
Büchi, A. E., Feller, M., Netzer, S., Blum, M. R., Gonzalez Rodriguez, E., Collet, T.-H., Del Giovane, C., van Heemst, D., Quinn, T., Kearney, P. M., Westendorp, R. G. J., Gussekloo, J., Mooijaart, S. P., Hans, D., Bauer, D. C., Rodondi, N., & Aeberli, D.
Affiliations
  • University of Bern (CH)
  • University Hospital of Geneva (CH)
  • University of Glasgow (GB)
  • University College Cork (IE)
  • University of Copenhagen (DK)
  • Leiden University Medical Center (NL)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • University of California, San Francisco (US)
  • University Hospital of Bern (CH)
Corresponding author
Aeberli, Daniel
Venue
Bone
Publisher
Elsevier BV
Published
2022-08
Volume
161
Pages
116404
ISSN
  • 1873-2763 (ISSN-L)
  • 8756-3282
OpenAlex
W4226072202
Cited by
14
References
9
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 4
FWCI
3.10
Type
journal article
Language
en
Open access
Locations
  • Bone (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • Open Access CRIS of the University of Bern
Funders
  • European Commission
  • Vontobel-Stiftung
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (278148, 320030-172676, 32003B_200606)
  • ZonMw
  • Schweizerische Herzstiftung
  • Fondation Leenaards
  • European Commission Seventh Framework Programme for Research and Technological Development Health
  • Horizon 2020 (627001001, 666869)
  • Velux Stiftung (974a, PZ00P3-167826)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
Keywords
subclinical hypothyroidism, levothyroxine, thyroid hormone replacement, bone geometry, volumetric bone mineral density, bone mineral content, older adults, peripheral quantitative computed tomography, TRUST trial, bone mass, osteoporosis, dose titration, radius, tibia, cortical thickness, cross-sectional area, trabecular bone density, placebo comparison, community-dwelling
MeSH terms
Aged, Bone and Bones, Female, Humans, Hypothyroidism, Male, Radius, Thyroxine, Tibia, Bone Density

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review